The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.
CAMBRIDGE, Mass. — Moderna has begun testing an omicron-specific COVID-19 booster in healthy adults.
The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer It’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant. The original vaccines still offer good protection against death and severe illness. and elsewhere show a booster dose strengthens that protection and improves the chances of avoiding even a milder infection.
Moderna pointed to a small study published in the New England Journal of Medicine on Wednesday that showed antibodies able to target omicron persisted for six months after a booster dose, although the levels were dropping. Moderna’s new study will enroll about 600 people who already have received either two doses of the company’s original shots or two plus a booster dose. All the volunteers will receive a dose of the experimental omicron-matched version.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Moderna begins testing omicron-specific COVID-19 vaccine in adultsIt’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant, since the original vaccines still offer good protection.
Baca lebih lajut »
Pfizer begins testing omicron-matched COVID shots in adultsPfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots.
Baca lebih lajut »
Moderna starts clinical trial of booster shot targeting omicron Covid variantThe first participant in the trial has already received a dose of the omicron-specific booster shot, according to Moderna.
Baca lebih lajut »
Moderna starts trial of an omicron-specific COVID-19 vaccineBoosters of the original still protect against omicron.
Baca lebih lajut »
Moderna starts trial on omicron-specific Covid booster in adultsModerna starts its clinical trial using an omicron-specific booster vaccine. Pfizer has also started testing a vaccine for omicron.
Baca lebih lajut »